In re: Palbociclib Patent Litigation

一、案件信息
起诉日期/案件已知起始日期：2019-10-02
最新文件提交日期：2020-12-09
案件发生国家/地区：美国
管辖法院/行政机关：D.Del.
法官信息：Colm Felix Connolly
诉讼编号：1:19-md-02912
诉讼名称：In re: Palbociclib Patent Litigation
案件状态：Open
赔偿金额：暂无

二、涉案知识产权信息
涉案知识产权类型：专利
专利权人：Warner Lambert Company
涉案专利申请号：US20030345778;US20050046126;US20070734200
涉案专利公开号：US6936612B2;US7208489B2;US7456168B2
专利名称：2-(Pyridin-2-ylamino)-pyrido[2, 3-d]pyrimidin-7-ones
涉案专利IPC：C07D401/14;A61K31/444;A61K31/519;A61K31/5377;A61K31/551;A61K31/675;A61P3/10;A61P9/10;A61P13/12;A61P15/00;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P31/10;A61P31/12;A61P31/18;A61P31/22;A61P35/00;A61P35/02;A61P37/06;A61P43/00;C07D471/04;C07F9/6561;
重点产业：医药健康

三、涉案当事人
原告：Pfizer (US);Warner-Lambert Company (US);Pf Prism (NL);Pfizer Manufacturing Holdings (US);Pfizer PFE Ireland Pharmaceuticals Holding (NL)
原告律师：暂无
原告律师律所：暂无
被告：Teva Pharmaceuticals Usa (US);Alembic Pharmaceuticals (IN);Aurobindo Pharma (IN);Hetero USA (US);Aurobindo Pharma USA (US);Sun Pharma Global (AE);Mylan Pharmaceuticals (US);Hetero Drugs (IN);Apotex (US);Cipla USA (US);Cipla (IN);Hetero Labs (IN);Sun Pharmaceutical Industries (IN);Mylan (US);Qilu Pharma (US);Dr. Reddy's Laboratories (US);Cadila Healthcare (IN);Natco Pharma (IN);Apotex (CA);Alembic Pharmaceuticals (US);Sun Pharmaceutical Industries (US);Qilu Pharmaceutical (CN);Hetero LABS UNIT-V (IN);Eugia Pharma Specialties (IN);Natco Pharma (US);Aizant Drug Research Solutions (IN);Zydus Worldwide DMCC (AE);TEVA Pharmaceuticals Industries (IL);Makro Technologies (CH);Dr. Reddy's Laboratories (IN);Zydus Pharmaceuticals (USA) (US)
被告律师：暂无
被告律师律所：暂无
第三方：暂无

四、案件审理结果
判决结果：暂无